One possible explanation for the putative effect modification from CVD can be that the reduction in MACE needs more time to become apparent among patients without previous CVD (Zelniker et al., 2019)
Youll need to share details about your health history, current medications, past weight-loss efforts, and any conditions that could make GLP-1s risky, including thyroid issues, pancreatitis, or gallbladder disease
I might only have to sit down
The Peptide Compliance Crisis In October 2023, the FDA issued warning letters to multiple peptide providers for marketing non-approved peptides as research chemicals while clearly selling them for human use
The treatment group receiving the GHK-based complex showed a statistically significant increase in hair count over 6 months compared to placebo 71.5 additional hairs in the treatment group versus 9.6 in the placebo group (Choi et al., 2016)